NO174207C - Analogous Process for Preparation of Therapeutically Active Conjugate of Diaphragm Anchor - Google Patents
Analogous Process for Preparation of Therapeutically Active Conjugate of Diaphragm AnchorInfo
- Publication number
- NO174207C NO174207C NO862511A NO862511A NO174207C NO 174207 C NO174207 C NO 174207C NO 862511 A NO862511 A NO 862511A NO 862511 A NO862511 A NO 862511A NO 174207 C NO174207 C NO 174207C
- Authority
- NO
- Norway
- Prior art keywords
- active ingredient
- preparation
- therapeutically active
- analogous process
- active conjugate
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Conjugates are described in which the active ingredient is covalently bonded to the anchoring membrane, which is a compound of the formulae <IMAGE> in which A can be: sulphur, oxygen, disulphide (-S-S-), methylene (-CH2-) or -NH-; n = 0 to 5; m = 1 or 2; C* = an asymmetric carbon atom of R or S configuration, R, R' and R'' are identical or different and are an alkyl, alkenyl or alkynyl group having 7 to 25 carbon atoms or are hydrogen which can optionally be substituted by hydroxyl, amino, oxo, acyl, alkyl or cycloalkyl groups and R1 and R2 are identical or different and are defined as R, R' or R'' or can be -OR, -OCOR, -COOR, -NHCOR or -CONHR and X is an active ingredient or a spacer active ingredient group. The anchoring membrane active ingredient conjugates increase antibody formation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO920356A NO920356D0 (en) | 1985-06-24 | 1992-01-27 | ANALOGUE PROCEDURE FOR PREPARING A CONJUGATE OF A MEMBRANEOUS-ACTIVE SUBSTANCE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3522512 | 1985-06-24 | ||
DE19853546150 DE3546150A1 (en) | 1985-06-24 | 1985-12-27 | MEMBRANE ANCHOR ACTIVE CONJUGATE, ITS PRODUCTION AND USE |
Publications (4)
Publication Number | Publication Date |
---|---|
NO862511D0 NO862511D0 (en) | 1986-06-23 |
NO862511L NO862511L (en) | 1986-12-29 |
NO174207B NO174207B (en) | 1993-12-20 |
NO174207C true NO174207C (en) | 1994-03-30 |
Family
ID=25833375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO862511A NO174207C (en) | 1985-06-24 | 1986-06-23 | Analogous Process for Preparation of Therapeutically Active Conjugate of Diaphragm Anchor |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0210412B1 (en) |
JP (1) | JP2594259B2 (en) |
KR (1) | KR930008091B1 (en) |
AT (1) | ATE131491T1 (en) |
AU (1) | AU611385B2 (en) |
CA (1) | CA1340656C (en) |
DE (2) | DE3546150A1 (en) |
DK (1) | DK172399B1 (en) |
ES (1) | ES8801677A1 (en) |
FI (1) | FI94419C (en) |
NO (1) | NO174207C (en) |
PT (1) | PT82826B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3813821A1 (en) * | 1988-04-22 | 1989-11-02 | Hoechst Ag | SYNTHETIC VACCINE AGAINST MOUTH AND CLAUS DISEASE AND METHOD FOR THEIR PRODUCTION |
US6074650A (en) * | 1985-06-24 | 2000-06-13 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
US6024964A (en) * | 1985-06-24 | 2000-02-15 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
DE3937412A1 (en) * | 1989-11-10 | 1991-05-16 | Hoechst Ag | SYNTHETIC VACCINE FOR THE SPECIFIC INDUCTION OF CYTOTOXIC T-LYMPHOZYTES |
CA1331355C (en) * | 1986-04-21 | 1994-08-09 | Bioenterprises Pty. Ltd | Immunopotentation |
AU619443B2 (en) * | 1986-04-21 | 1992-01-30 | Bioenterprises Pty. Ltd. | Immunopotentiation |
JPS63107742A (en) * | 1986-05-20 | 1988-05-12 | Wako Pure Chem Ind Ltd | Novel functional liposome and its preparation |
DE3700173A1 (en) * | 1987-01-05 | 1988-07-14 | Hoechst Ag | METHOD FOR PRODUCING LIPOPHILE AMINO ACID DERIVATIVES AND LIPOPHILE AMINO ACID DERIVATIVES |
US5976839A (en) * | 1987-03-13 | 1999-11-02 | Bioenterprises Pty Limited | Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules |
GB2217319A (en) * | 1988-04-19 | 1989-10-25 | Synpharm Ltd | Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi |
US5120829A (en) * | 1989-03-20 | 1992-06-09 | La Jolla Cancer Research Foundation | Hydrophobic attachment site for adhesion peptides |
JP2640293B2 (en) * | 1990-05-30 | 1997-08-13 | ドイチエス クレープスフオルシユングスツエントルム ステイフツング デス アフエントリヒエン レヒトス | Polyether-substituted antitumor agent |
DE4119856A1 (en) * | 1991-06-17 | 1992-12-24 | Hoechst Ag | N-ACYL-S- (2-HYDROXYALKYL) -CYSTEINS, THE PRODUCTION AND USE THEREOF AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF SYNTHETIC IMMUNE ADJUVANTS AND SYNTHETIC VACCINANTS |
AU666789B2 (en) * | 1992-12-28 | 1996-02-22 | Takeda Chemical Industries Ltd. | 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
EP0604945A1 (en) * | 1992-12-28 | 1994-07-06 | Takeda Chemical Industries, Ltd. | TAN-1511, its derivatives, production and use thereof |
DE4325317C2 (en) * | 1993-07-29 | 1998-05-20 | Univ Dresden Tech | Process for the radioactive labeling of immunoglobulins |
DE4329309A1 (en) * | 1993-08-31 | 1995-03-09 | Rapp Polymere Gmbh | Lipopeptide compounds |
EP0641776A3 (en) * | 1993-09-08 | 1997-05-02 | Takeda Chemical Industries Ltd | Thioglycerol derivatives. |
FR2727117A1 (en) * | 1994-11-18 | 1996-05-24 | Geffard Michel | USE OF POLYLYSIN CONJUGATES FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES AND DEGENERATIVE DISORDERS OF AUTOIMMUN CHARACTER |
US6117940A (en) * | 1997-10-17 | 2000-09-12 | Mjalli; Adnan M. M. | Amino-ketone solid support templates |
IL125908A (en) | 1998-08-24 | 2005-05-17 | Nst Neurosurvival Technologies | Peptides and pharmaceutical compositions comprising same |
IL131266A0 (en) * | 1999-08-05 | 2001-01-28 | N S T Neurosurvival Technologi | Peptides and pharmaceutical compositions comprising same |
GB9915074D0 (en) * | 1999-06-28 | 1999-08-25 | Cortecs Plc | Ligand-binding composition |
DE102009034779A1 (en) | 2009-07-25 | 2011-02-03 | Emc Microcollections Gmbh | Synthetic analogues of bacterial lipopeptides and their application for the therapy and prophylaxis of allergic diseases |
EA023725B1 (en) * | 2010-03-23 | 2016-07-29 | Новартис Аг | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
DE102011018499A1 (en) | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topical nanoparticle vaccine for the immune stimulation of dendritic cells in the skin |
US10766928B2 (en) | 2012-10-05 | 2020-09-08 | The University Of Kansas | Targeted conformationally-constrained kinked endosomal disrupting peptides |
US9701715B2 (en) * | 2012-10-05 | 2017-07-11 | The University Of Kansas | Conformationally-constrained kinked endosomal-disrupting peptides |
KR20160147960A (en) | 2014-04-25 | 2016-12-23 | 아지노모토 가부시키가이샤 | Immunostimulating agent |
DE102016005550A1 (en) | 2016-05-09 | 2017-11-09 | Emc Microcollections Gmbh | Adjuvant for the induction of a cellular immune response |
TWI762706B (en) | 2017-08-24 | 2022-05-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1 compositions and uses thereof |
BR112022013795A2 (en) | 2020-02-18 | 2022-09-13 | Novo Nordisk As | LIQUID PHARMACEUTICAL COMPOSITION AND KIT |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0000330B1 (en) * | 1977-06-20 | 1981-08-05 | Ciba-Geigy Ag | Lipopeptides, process for their preparation and pharmaceutical compositions containing them |
US4125569A (en) | 1977-08-25 | 1978-11-14 | Mobil Oil Corporation | Process for increasing hydrogenation rate of polymerized n-alphaolefins |
EP0014815A3 (en) * | 1978-12-20 | 1980-10-29 | Ciba-Geigy Ag | Peptide derivatives, process for their preparation and intermediates, and pharmaceutical compositions containing one of these compounds |
ATE67769T1 (en) | 1983-01-25 | 1991-10-15 | Ciba Geigy Ag | NEW PEPTIDE DERIVATIVES. |
-
1985
- 1985-12-27 DE DE19853546150 patent/DE3546150A1/en not_active Withdrawn
-
1986
- 1986-06-19 AT AT86108324T patent/ATE131491T1/en not_active IP Right Cessation
- 1986-06-19 EP EP86108324A patent/EP0210412B1/en not_active Expired - Lifetime
- 1986-06-19 DE DE3650448T patent/DE3650448D1/en not_active Expired - Lifetime
- 1986-06-19 FI FI862631A patent/FI94419C/en not_active IP Right Cessation
- 1986-06-23 DK DK294086A patent/DK172399B1/en not_active IP Right Cessation
- 1986-06-23 PT PT82826A patent/PT82826B/en unknown
- 1986-06-23 CA CA000512181A patent/CA1340656C/en not_active Expired - Fee Related
- 1986-06-23 JP JP61145031A patent/JP2594259B2/en not_active Expired - Lifetime
- 1986-06-23 AU AU58943/86A patent/AU611385B2/en not_active Expired
- 1986-06-23 ES ES556417A patent/ES8801677A1/en not_active Expired
- 1986-06-23 NO NO862511A patent/NO174207C/en not_active IP Right Cessation
- 1986-06-24 KR KR8605055A patent/KR930008091B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3650448D1 (en) | 1996-01-25 |
EP0210412A3 (en) | 1990-02-07 |
NO862511L (en) | 1986-12-29 |
KR870000359A (en) | 1987-02-18 |
AU611385B2 (en) | 1991-06-13 |
FI94419C (en) | 1995-09-11 |
JPS6263600A (en) | 1987-03-20 |
DK294086A (en) | 1986-12-25 |
AU5894386A (en) | 1987-01-08 |
KR930008091B1 (en) | 1993-08-25 |
DK172399B1 (en) | 1998-05-18 |
NO174207B (en) | 1993-12-20 |
JP2594259B2 (en) | 1997-03-26 |
ES556417A0 (en) | 1988-02-16 |
DE3546150A1 (en) | 1987-01-22 |
PT82826B (en) | 1989-01-17 |
FI94419B (en) | 1995-05-31 |
FI862631A (en) | 1986-12-25 |
EP0210412B1 (en) | 1995-12-13 |
ATE131491T1 (en) | 1995-12-15 |
EP0210412A2 (en) | 1987-02-04 |
CA1340656C (en) | 1999-07-20 |
PT82826A (en) | 1986-07-01 |
ES8801677A1 (en) | 1988-02-16 |
NO862511D0 (en) | 1986-06-23 |
DK294086D0 (en) | 1986-06-23 |
FI862631A0 (en) | 1986-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO174207C (en) | Analogous Process for Preparation of Therapeutically Active Conjugate of Diaphragm Anchor | |
FI905575A0 (en) | NY POLYPEPTIDFOERENING OCH FOERFARANDE FOER DESS FRAMSTAELLNING. | |
PT79735A (en) | 11BETA-ARYL ESTRADIENES OF THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF | |
DE3650265D1 (en) | Macrolide antibiotics and process for their preparation. | |
NO178923C (en) | Analogous Process for Preparation of Therapeutically Active 24-Homo Vitamin D Derivatives | |
KR890014098A (en) | Prophylaxis and treatment of central neurodegenerative diseases containing catechol amine derivatives | |
FR2649110B1 (en) | NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
SE7611145L (en) | WAY TO MANUFACTURE DELTA? 7215 STEROIDS | |
ATE143962T1 (en) | PTERINE DERIVATIVES AND ITS APPLICATION FOR THE PRODUCTION OF IMMUNO TESTING METHODS | |
FR2660657B1 (en) | NOVEL 3-AMINOCHROMANE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ATE27270T1 (en) | THIOESTER OF ACETYLSALICYLIC ACID, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
DE69624121D1 (en) | MEMBRANES POSSENDING SECOND MESSENGERS | |
PL287073A1 (en) | Method of obtaining novel derivatives of benzanilide | |
ES546995A0 (en) | PROCEDURE FOR THE PREPARATION OF PREGNANO DERIVATIVES | |
KR960703612A (en) | NOVEL TRIPEPTIDES USEFUL IN IMMUNE AND CNS THERAPY for the Treatment of Immune and Central Nervous System | |
DK613989D0 (en) | USE OF SUBSTITUTED BENZAMIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH GAS TROMOTORIC EFFECT | |
ATE43594T1 (en) | 3-ALKOXY-2-(N-PYRROLIDINO)-N-PYRIDYL-N-FURYL(OD R THIENYL)-METHYL-PROPYLAMINE, THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM. | |
KR880012232A (en) | Anti-obesity agents | |
ES2016931B3 (en) | Procedure for the preparation of new aliphatic and cycloaliphatic amides of pyridylalkylamines or their N-oxide derivatives. | |
BR9610229A (en) | Polyhydroxyalkylamidamine oxides | |
NO160438C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBACYCLINE DERIVATIVES. | |
EP0081455A3 (en) | 9-bromo-prostaglandin derivatives, their preparation and pharmaceutical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |